Jonathan W. Kowalski

9.2k citations

42 papers · 3.3k indexed · 2 hit papers · h-index 25

Ophthalmology top 0.2%
Radiology, Nuclear Medicine and Imaging top 1%
Physiology top 2%
Neurology top 2%
Rheumatology top 2%

Co-authors: Tien Yin Wong Hiep Nguyen Rachel McIntosh Lyndell L. Lim Ning Cheung Jie Jin Wang Sophie Rogers Dee Anna Glaser
Topics: Retinal Diseases and Treatments (18 papers)Retinal and Optic Conditions (11 papers)Retinal Imaging and Analysis (9 papers)
Cited by: Ophthalmology Radiology, Nuclear Medicine and Imaging Neurology
Journals: Ophthalmology The Journal of Urology European Urology
Partner nations: United States United Kingdom Ireland

In The Last Decade

Jonathan W. Kowalski

41 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia

2009 827 citations Sophie Rogers, Rachel McIntosh et al. Ophthalmology profile →
Natural History of Central Retinal Vein Occlusion: An Evidence-Based Systematic Review

2010 467 citations Rachel McIntosh, Sophie Rogers et al. Ophthalmology profile →

Peers

Countries citing papers authored by Jonathan W. Kowalski

Since Specialization

Citations

This map shows the geographic impact of Jonathan W. Kowalski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan W. Kowalski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan W. Kowalski more than expected).

Fields of papers citing papers by Jonathan W. Kowalski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan W. Kowalski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan W. Kowalski. The network helps show where Jonathan W. Kowalski may publish in the future.

Co-authorship network of co-authors of Jonathan W. Kowalski

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan W. Kowalski. A scholar is included among the top collaborators of Jonathan W. Kowalski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan W. Kowalski. Jonathan W. Kowalski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real World Vision Outcomes in DME Treated with Anti-VEGF Injections - An Analysis of EMR Data From a Large Health System 2014 ·Investigative Ophthalmology & Visual Science ·(unknown),Ashley L. Cole,Joanna Campbell,Herbert J. Ingraham,Arghavan Almony,Szilárd Kiss,Steven J. Marks,Jonathan W. Kowalski,Nancy M. Holekamp	12
2	Clinical Utilization of Anti-VEGF Agents and Disease Monitoring in Neovascular Age-Related Macular Degeneration 2014 ·American Journal of Ophthalmology ·Nancy M. Holekamp,Ying Liu,Wei‐Shi Yeh,(unknown),Szilárd Kiss,Arghavan Almony,Jonathan W. Kowalski	75
3	Effects of OnabotulinumtoxinA Treatment for Crow's Feet Lines on Patient-Reported Outcomes 2014 ·Dermatologic Surgery ·Steven Dayan,William P. Coleman,Jeffrey S. Dover,Koen De Boulle,James C. Street,(unknown),Selena Daniels,Jonathan W. Kowalski,Xiaofang Lei,Elisabeth Lee	25
4	Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema 2014 ·Clinical ophthalmology ·Szilárd Kiss,Ying Liu,Joseph G. Brown,Nancy M. Holekamp,Arghavan Almony,Joanna Campbell,Jonathan W. Kowalski	96
5	Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions 2014 ·Clinical ophthalmology ·Joanna Campbell,(unknown),(unknown),Jonathan W. Kowalski,Patel	13
6	Psychometric Performance of the Incontinence Quality-of-Life Questionnaire Among Patients With Overactive Bladder and Urinary Incontinence 2013 ·Clinical Therapeutics ·Donald L. Patrick,Kristin Khalaf,Roger R. Dmochowski,Jonathan W. Kowalski,Denise Globe	30
7	Comparison of adherence and persistence with bimatoprost 0.01% versus bimatoprost 0.03% topical ophthalmic solutions 2013 ·Current Medical Research and Opinion ·Joanna Campbell,Gail F. Schwartz,(unknown),Jonathan W. Kowalski,Vaishali Patel	12
8	Normative Comparison of Patient-Reported Outcomes in Patients With Noninfectious Uveitis 2013 ·JAMA Ophthalmology ·(unknown),Anne M. Rentz,C. Stephen Foster,Susan Lightman,Rubens Belfort,Careen Y. Lowder,Scott M. Whitcup,Jonathan W. Kowalski,Dennis A. Revicki	37
9	An adherence based cost–consequence model comparing bimatoprost 0.01% to bimatoprost 0.03% 2013 ·Current Medical Research and Opinion ·William B. Wong,Vaishali Patel,Jonathan W. Kowalski,Gail F. Schwartz	3
10	Psychometric evaluation of the National Eye Institute Visual Function Questionnaire and Visual Function Questionnaire Utility Index in patients with non-infectious intermediate and posterior uveitis 2013 ·Quality of Life Research ·(unknown),Katharine S. Gries,Anne M. Rentz,Jonathan W. Kowalski,Dennis A. Revicki	29
11	OnabotulinumtoxinA Improves Health-Related Quality of Life in Patients With Urinary Incontinence Due to Idiopathic Overactive Bladder: A 36-Week, Double-Blind, Placebo-Controlled, Randomized, Dose-Ranging Trial 2012 ·European Urology ·Clare J. Fowler,Stephen M. Auerbach,David A. Ginsberg,Douglass S. Hale,Piotr Radziszewski,Tomasz Rechberger,Vaishali Patel,Jihao Zhou,Catherine Thompson,Jonathan W. Kowalski	61
12	Effect of the Duration of Macular Edema on Clinical Outcomes in Retinal Vein Occlusion Treated with Dexamethasone Intravitreal Implant 2012 ·Ophthalmology ·Wei‐Shi Yeh,Julia A. Haller,Paolo Lanzetta,Baruch D. Kuppermann,Tien Yin Wong,Paul Mitchell,Scott M. Whitcup,Jonathan W. Kowalski	84
13	Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes 2010 ·Quality of Life Research ·William Hollingworth,Jonathan D. Campbell,Jonathan W. Kowalski,Arliene Ravelo,I Girod,Andrew Briggs,Sean D. Sullivan	14
14	Natural History of Branch Retinal Vein Occlusion: An Evidence-Based Systematic Review 2010 ·Ophthalmology ·Sophie Rogers,Rachel McIntosh,Lyndell L. Lim,Paul Mitchell,Ning Cheung,Jonathan W. Kowalski,Hiep Nguyen,Jie Jin Wang,Tien Yin Wong	315
15	Cost Analysis of Interventions for Antimuscarinic Refractory Patients With Overactive Bladder 2010 ·Urology ·Jonathan H. Watanabe,Jonathan D. Campbell,Arliene Ravelo,Michael B. Chancellor,Jonathan W. Kowalski,Sean D. Sullivan	27
16	The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australiabreakdown → 2009 ·Ophthalmology ·Sophie Rogers,Rachel McIntosh,Ning Cheung,Lyndell L. Lim,Jie Jin Wang,Paul Mitchell,Jonathan W. Kowalski,Hiep Nguyen,Tien Yin Wong	827
17	Patient‐Reported Outcomes with Botulinum Toxin Type A Treatment of Glabellar Rhytids 2007 ·Dermatologic Surgery ·Steven Fagien,Sue Ellen Cox,(unknown),Wm. Philip Werschler,Jonathan W. Kowalski	72
18	Patient-Reported Benefit and Satisfaction with Botulinum Toxin Type A Treatment of Moderate to Severe Glabellar Rhytides: Results from a Prospective Open-Label Study 2007 ·Plastic & Reconstructive Surgery ·Mitchell A. Stotland,Jonathan W. Kowalski,(unknown)	48
19	Primary Focal Hyperhidrosis: Disease Characteristics and Functional Impairment 2006 ·Dermatology ·Henning Hamm,Markus Naumann,Jonathan W. Kowalski,(unknown),Chris M Kozma,(unknown)	110
20	US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: Results from a national survey 2004 ·Journal of the American Academy of Dermatology ·David Strutton,Jonathan W. Kowalski,(unknown),Dee Anna Glaser,Paul Stang	442

About Jonathan W. Kowalski

Jonathan W. Kowalski is a scholar working on Ophthalmology, Urology and Dermatology, having authored 42 papers that have together received 3.3k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (18 papers), Retinal and Optic Conditions (11 papers) and Retinal Imaging and Analysis (9 papers). The work is most often cited by research in Ophthalmology (2.0k citations), Radiology, Nuclear Medicine and Imaging (1.3k citations) and Neurology (531 citations). Jonathan W. Kowalski has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Tien Yin Wong, Hiep Nguyen, Rachel McIntosh, Lyndell L. Lim, Ning Cheung, Jie Jin Wang, Sophie Rogers, Dee Anna Glaser, Paul Mitchell and Paul Mitchell. Their work appears in journals such as Ophthalmology, The Journal of Urology and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact